The biosimilar testing guidelines state that at least 6-10 batches of your biosimilar should be compared to at least 6-10 batches of innovator product. This may be done over multiple comparability studies. Any fewer batches than this and it is difficult to make any statistical claims of biosimiliarity. Further information on designing your comparability study plan can be found here.